ArticleBMC infectious diseases2026
Hidden burden of hepatitis B: occult HBV infection in vaccinated offspring of HBsAg-positive mothers in an endemic area.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Occult Hepatitis B virus infection (OBI) is prevalent among high-risk and immunized populations in regions with high endemicity. OBI could be reactivated and/or transmitted, making it a significant risk factor for liver disease progression, including cirrhosis and hepatocellular carcinoma. This cross-sectional study was conducted on vaccinated children born to HBsAg positive mothers in the Esfandiar region of Iran. Families with a member who tested positive for HBV were included in the study. Blood samples were collected, and serological assays were performed to detect anti-HBc, HBsAg, anti-HBs, and HBeAg. Molecular examinations, including DNA extraction, PCR assays and real-time PCR quantification, were performed to identify OBI. Subsequently, the amplified segment of the S gene underwent DNA sequencing for mutations analysis and HBV genotyping. In total, 100 children were examined: Serological assessments indicated positive results for anti-HBs, anti-HBc, and HBsAg in 43%, 5%, and 2% of cases, respectively. PCR assays revealed 6.1% prevalence of OBI (95% CI: 0.013-0.11). Phylogenetic analysis confirmed that all isolates belonged to HBV genotype D and sub-genotype D1. Mutational analysis identified immune escape mutations in the HBsAg protein, including T45N, P105A, and Q129H. The findings suggest a suboptimal protective efficacy of the HBV vaccine in this highly endemic region. The presence of OBI among vaccinated individuals highlights the potential for transmission through congenital and perinatal routes. Screening of mothers and women of childbearing age, administration of HBV immunoglobulin, and reinforcement of Hepatitis B vaccination programs are imperative in such regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.